BioHarvest Sciences (TSE:BHSC) has released an update.
BioHarvest Sciences Inc. has achieved a record-breaking $2 million in monthly sales for May 2024, doubling its sales orders year-over-year, driven by the success of its VINIA® product subscriptions. The company’s growth is bolstered by customer loyalty, with over 5,000 reviews averaging a 4.8 out of 5 satisfaction rating, and a diverse range of new ‘VINIA Inside’ products poised to further drive revenue. Amidst this surge, BioHarvest is preparing to introduce new VINIA® product lines and is on track for projected second-quarter revenues of $5.7-6.0 million, with sights set on a Nasdaq uplisting by the year’s end.
For further insights into TSE:BHSC stock, check out TipRanks’ Stock Analysis page.
